40 related articles for article (PubMed ID: 36183194)
1. Impact of the 99DOTS digital adherence technology on tuberculosis treatment outcomes in North India: a pre-post study.
Chen AZ; Kumar R; Baria RK; Shridhar PK; Subbaraman R; Thies W
BMC Infect Dis; 2023 Jul; 23(1):504. PubMed ID: 37525114
[TBL] [Abstract][Full Text] [Related]
2. Counseling intervention improves treatment adherence among newly diagnosed drug sensitive Tuberculosis patients of Ahmedabad city - A mixed methods approach.
Raval D; Patel P; Sharma R; Shringarpure K
Indian J Tuberc; 2024 Jan; 71(1):19-26. PubMed ID: 38296385
[TBL] [Abstract][Full Text] [Related]
3. The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy.
Lee CS; Ho CH; Liao KM; Wu YC; Shu CC
J Infect Public Health; 2023 Nov; 16(11):1778-1783. PubMed ID: 37738694
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of clinical profiles, imaging findings and antituberculosis treatment outcome in granulomatous mastitis: An Indian scenario.
Mithen R; Mahin Nallasivam RR; Thangaswamy D; Mohanapriya T
Indian J Tuberc; 2024 Apr; 71(2):163-169. PubMed ID: 38589120
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Diagnosis and Treatment of Otorhinolaryngological, Head and Neck Tuberculosis: A Prospective Clinical Study.
Chhabra B; Vyas P; Gupta P; Sharma P; Sharma K
Int Arch Otorhinolaryngol; 2023 Oct; 27(4):e630-e635. PubMed ID: 37876691
[No Abstract] [Full Text] [Related]
6. Quantifying non-adherence to anti-tuberculosis treatment due to early discontinuation: a systematic literature review of timings to loss to follow-up.
Walker EF; Flook M; Rodger AJ; Fielding KL; Stagg HR
BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38359965
[TBL] [Abstract][Full Text] [Related]
7. Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study.
Gorityala SB; Mateti UV; Konuru V; Martha S
J Pharm Bioallied Sci; 2015; 7(3):226-9. PubMed ID: 26229358
[TBL] [Abstract][Full Text] [Related]
8. Manifestations of Tuberculosis in Otorhinolaryngology Practice: A Retrospective Study Conducted in a Coastal City of South India.
Sriram R; Bhojwani KM
Indian J Otolaryngol Head Neck Surg; 2017 Jun; 69(2):210-215. PubMed ID: 28607892
[TBL] [Abstract][Full Text] [Related]
9. Participation of private providers in the National TB Programme in South India.
Meundi AD; Richardus JH
Public Health Action; 2023 Dec; 13(4):142-147. PubMed ID: 38077727
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Factors Associated With Anti-Tubercular Treatment Compliance in Children: A Cross-Sectional Study.
Gao L; Luo B
Glob Pediatr Health; 2024; 11():2333794X231199360. PubMed ID: 38405015
[No Abstract] [Full Text] [Related]
11. Measurement of isoniazid in tuberculosis patients using finger sweat with creatinine normalisation: A controlled administration study.
Longman K; Akkerman OW; Ghimire S; Bolhuis MS; Chambers MA; Sturkenboom MGG; Bailey MJ
Int J Antimicrob Agents; 2024 Jun; ():107231. PubMed ID: 38918168
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled Trial.
Perumal Kannabiran B; Palaniappan NA; Manoharan T; Paramasivam PK; Saini JK; Ansari MS; Jayabal L; Aggarwal AN; Garg R; Subramanyam B; Thakur D; Pantula S; P M R; Gs V; Natarajan S; Ammayappan RK; Manpreet B; Ganesan M; Angamuthu D; Chinnaiyan P; Singh M; Chandrasekaran P; Swaminathan S
Open Forum Infect Dis; 2024 Mar; 11(3):ofae034. PubMed ID: 38444824
[TBL] [Abstract][Full Text] [Related]
13. Adherence to treatment on a daily-dose regimen for TB.
Rajavardhana T; Koushik MR; Jayakumar C; Ramalingam P; Geethavani M; Kumar MA; Rajanandh MG
Int J Tuberc Lung Dis; 2023 Oct; 27(10):778-780. PubMed ID: 37749830
[No Abstract] [Full Text] [Related]
14. Clinical standards for the management of adverse effects during treatment for TB.
Singh KP; Carvalho ACC; Centis R; D Ambrosio L; Migliori GB; Mpagama SG; Nguyen BC; Aarnoutse RE; Aleksa A; van Altena R; Bhavani PK; Bolhuis MS; Borisov S; van T Boveneind-Vrubleuskaya N; Bruchfeld J; Caminero JA; Carvalho I; Cho JG; Davies Forsman L; Dedicoat M; Dheda K; Dooley K; Furin J; García-García JM; Garcia-Prats A; Hesseling AC; Heysell SK; Hu Y; Kim HY; Manga S; Marais BJ; Margineanu I; Märtson AG; Munoz Torrico M; Nataprawira HM; Nunes E; Ong CWM; Otto-Knapp R; Palmero DJ; Peloquin CA; Rendon A; Rossato Silva D; Ruslami R; Saktiawati AMI; Santoso P; Schaaf HS; Seaworth B; Simonsson USH; Singla R; Skrahina A; Solovic I; Srivastava S; Stocker SL; Sturkenboom MGG; Svensson EM; Tadolini M; Thomas TA; Tiberi S; Trubiano J; Udwadia ZF; Verhage AR; Vu DH; Akkerman OW; Alffenaar JWC; Denholm JT
Int J Tuberc Lung Dis; 2023 Jul; 27(7):506-519. PubMed ID: 37353868
[TBL] [Abstract][Full Text] [Related]
15. Level of adherence to anti-tubercular treatment among drug-sensitive tuberculosis patients on a newly introduced daily dose regimen in South India: A cross-sectional study.
Thamineni R; Peraman R; Chenniah J; Meka G; Munagala AK; Mahalingam VT; Ganesan RM
Trop Med Int Health; 2022 Nov; 27(11):1013-1023. PubMed ID: 36183194
[TBL] [Abstract][Full Text] [Related]
16. Adherence to Isoniazid Preventive Therapy among children living with tuberculosis patients in Delhi, India: An exploratory prospective study.
Sharma N; Basu S; Khanna A; Sharma P; Chopra KK; Chandra S
Indian J Tuberc; 2022 Jan; 69(1):100-103. PubMed ID: 35074140
[TBL] [Abstract][Full Text] [Related]
17. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
[TBL] [Abstract][Full Text] [Related]
18. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
19. Six-month therapy for abdominal tuberculosis.
Jullien S; Jain S; Ryan H; Ahuja V
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012163. PubMed ID: 27801499
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
